• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Uncommon adverse effect of a common medication.

作者信息

Moore Kari Lenita Falck, Kildahl-Andersen Odd, Kildahl-Andersen Randi, Tjønnfjord Geir E

机构信息

University Hospital of Northern Norway, Harstad, Norway.

出版信息

Tidsskr Nor Laegeforen. 2013 Jan 22;133(2):165. doi: 10.4045/tidsskr.12.0494.

DOI:10.4045/tidsskr.12.0494
PMID:23344600
Abstract
摘要

相似文献

1
Uncommon adverse effect of a common medication.一种常用药物的罕见不良反应。
Tidsskr Nor Laegeforen. 2013 Jan 22;133(2):165. doi: 10.4045/tidsskr.12.0494.
2
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.长期服用含糖氧化铁导致的成纤维细胞生长因子23相关骨软化症
Intern Med. 2012;51(17):2375-8. doi: 10.2169/internalmedicine.51.7450. Epub 2012 Sep 1.
3
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia.布罗索尤单抗在难治性铁诱导的成纤维细胞生长因子23介导的低磷性骨软化症中的新用途。
Rheumatology (Oxford). 2020 Aug 1;59(8):2166-2168. doi: 10.1093/rheumatology/kez627.
4
Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.静脉注射蔗糖铁：妊娠期缺铁性贫血口服铁剂的替代选择。
Ann Hematol. 2015 Mar;94(3):523-5. doi: 10.1007/s00277-014-2189-7. Epub 2014 Aug 16.
5
Ferumoxytol: an intravenous iron, riskier than iron sucrose.菲洛维（注射用铁蔗糖）：一种静脉注射铁剂，比蔗糖铁风险更高。
Prescrire Int. 2013 Sep;22(141):206.
6
[Bone and Nutrition. The relationship between iron and phosphate metabolism].[骨骼与营养。铁与磷代谢之间的关系]
Clin Calcium. 2015 Jul;25(7):1037-42.
7
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.比较羧基麦芽糖铁和蔗糖铁治疗因异常子宫出血导致的缺铁性贫血的随机对照试验。
Int J Gynaecol Obstet. 2016 Apr;133(1):43-8. doi: 10.1016/j.ijgo.2015.09.007. Epub 2015 Dec 23.
8
Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration.因使用羧基麦芽糖铁导致的基于成纤维细胞生长因子23的严重低磷性骨软化症。
BMJ Case Rep. 2018 Jan 3;2018:bcr-2017-222851. doi: 10.1136/bcr-2017-222851.
9
Case report: A rare cause of severe hypophosphatemia.病例报告：严重低磷血症的罕见病因。
Ann Endocrinol (Paris). 2020 Jun;81(2-3):125-126. doi: 10.1016/j.ando.2020.04.008. Epub 2020 May 4.
10
Review of available intravenous iron preparations in hemodialysis.血液透析中可用静脉铁剂的综述。
CANNT J. 2013 Apr-Jun;23(2):51-4; quiz 55-6.

引用本文的文献

1
Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports.静脉铁输注的并发症：病例报告的系统评价。
J Bone Miner Res. 2022 Jun;37(6):1188-1199. doi: 10.1002/jbmr.4558. Epub 2022 May 7.
2
Parenteral iron therapy and phosphorus homeostasis: A review.肠外铁治疗与磷稳态：综述。
Am J Hematol. 2021 May 1;96(5):606-616. doi: 10.1002/ajh.26100. Epub 2021 Feb 9.
3
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.
对45项使用羧基麦芽糖铁的干预性试验中血清磷酸盐测量值和潜在低磷血症事件的汇总分析。
J Clin Med. 2020 Nov 6;9(11):3587. doi: 10.3390/jcm9113587.
4
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.羧基麦芽糖铁对矿物质和骨代谢标志物的影响：一项针对缺铁女性的单中心前瞻性观察研究。
Bone. 2020 Dec;141:115559. doi: 10.1016/j.bone.2020.115559. Epub 2020 Jul 28.
5
Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review.缺铁性贫血静脉铁剂治疗相关的低磷血症：一项系统文献综述
Ther Clin Risk Manag. 2020 Apr 8;16:245-259. doi: 10.2147/TCRM.S243462. eCollection 2020.
6
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk.高剂量静脉铁剂的选择决定了低磷血症风险。
PLoS One. 2016 Dec 1;11(12):e0167146. doi: 10.1371/journal.pone.0167146. eCollection 2016.
7
Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia.异麦芽糖酐铁（Monofer(®)）治疗缺铁性贫血患者的疗效和安全性
Int J Nephrol Renovasc Dis. 2016 Mar 10;9:53-64. doi: 10.2147/IJNRD.S89704. eCollection 2016.
8
Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia.缺铁性贫血患者使用静脉注射羧麦芽糖铁的经验。
Ther Adv Hematol. 2014 Apr;5(2):48-60. doi: 10.1177/2040620714521127.